ConvaTec Group PLC (LON:CTEC - Get Free Report) was up 6.9% on Wednesday . The company traded as high as GBX 249.69 ($3.36) and last traded at GBX 247.12 ($3.33). Approximately 13,084,437 shares traded hands during trading, a decline of 4% from the average daily volume of 13,697,891 shares. The stock had previously closed at GBX 231.20 ($3.11).
Analysts Set New Price Targets
A number of equities research analysts have weighed in on CTEC shares. Berenberg Bank decreased their target price on ConvaTec Group from GBX 335 to GBX 330 and set a "buy" rating for the company in a research report on Tuesday. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of ConvaTec Group in a research report on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, July 30th. Finally, Peel Hunt reaffirmed an "add" rating and set a GBX 280 target price on shares of ConvaTec Group in a research report on Tuesday, July 29th. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, ConvaTec Group currently has an average rating of "Buy" and an average target price of GBX 308.
Get Our Latest Analysis on CTEC
ConvaTec Group Trading Down 0.1%
The stock has a market capitalization of £6.20 billion, a P/E ratio of 41.09, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The company has a 50-day moving average price of GBX 254.47 and a 200 day moving average price of GBX 257.89.
Insider Activity at ConvaTec Group
In related news, insider Karim Bitar sold 1,250,000 shares of the company's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of GBX 227, for a total transaction of £2,837,500. Insiders own 19.65% of the company's stock.
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.